Age at Coronary Heart Disease Onset, Genetic Susceptibility, and Subsequent Risk of Stroke

Yi Qi1,2, Wen-Hao Liu1,3,4, Qing-Yuan Gao1,3,4

  • 1Department of Cardiology Sun Yat-sen Memorial Hospital, Sun Yat-sen University Guangzhou China.

Insights

Earlier onset of coronary heart disease (CHD) significantly increases stroke risk, including hemorrhagic and ischemic types. This heightened risk is independent of genetic factors, suggesting CHD onset age is a key stroke predictor.

Area of Science:

  • Cardiovascular Medicine
  • Neurology
  • Genetics

Background:

  • Coronary heart disease (CHD) is a known stroke risk factor.
  • The relationship between age of CHD onset and stroke risk requires further investigation.
  • Understanding genetic influences on stroke susceptibility is crucial.

Purpose of the Study:

  • To evaluate how age at coronary heart disease (CHD) onset affects stroke risk.
  • To determine if genetic predisposition to stroke interacts with age at CHD onset.
  • To analyze associations with specific stroke types: hemorrhagic and ischemic.

Main Methods:

  • Prospective cohort study utilizing UK Biobank data.
  • Inclusion criteria: participants without prior stroke or CHD.
  • Assessment of genetic susceptibility using polygenic risk scores.
  • Statistical analysis via Cox models and propensity score matching.
  • Interaction analysis using bootstrap methods and likelihood tests.

Main Results:

  • Increased stroke risk observed in participants with CHD.
  • Each 10-year earlier CHD onset correlated with higher stroke risk (HR 1.27).
  • Earlier CHD onset (<57 years) significantly increased subsequent stroke risk (HR 1.33).
  • No significant interaction found between CHD onset age and genetic stroke risk.

Conclusions:

  • Earlier coronary heart disease (CHD) onset is an independent predictor of increased stroke risk.
  • The association between earlier CHD onset and stroke risk persists regardless of genetic predisposition.
  • Early CHD onset serves as a critical marker for elevated stroke risk.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.8K
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
155
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.0K
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
113
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
887
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
3.8K